2988115
Last Update Posted: 2020-04-03
Recruiting has ended
All Genders accepted | 18 Years + |
345 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
Eligibility
Relevant conditions:
Hypercholesterolemia
Atherosclerotic Cardiovascular Disease
Statin Adverse Reaction
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov